Gene therapy is a promising treatment for mesothelioma, but it has been slow to make its way into clinical use because delivering enough therapeutic genes to effectively kill large numbers of cancer cells has proved challenging. Recently, mesothelioma researchers have been focusing on a method called immuno-gene therapy, which transfers just enough genetic material to trigger the patient’s own immune system to fight the cancer, according to a recent review published in the American Journal of Respiratory Cell and Molecular Biology. Researchers have been investigating the use of gene therapy – introducing a gene or genes into the body that kill cancer cells or make those cells more sensitive to the effects of anticancer drugs – for approximately two decades. … Continue reading Mesothelioma May Benefit From Immuno-Gene Therapy »